HSA to expand role in accelerating biomedical sector growth: Ong Ye Kung

The authority plans to strengthen its position as a global reference regulator.

The Health Sciences Authority (HSA) will expand its role beyond regulation as part of efforts to grow Singapore’s biomedical sector, according to Health Minister Ong Ye Kung.

The HSA will pursue three key initiatives, Ong said in his speech at the 29th session of the International Medical Device Regulators Forum.

The authority will strengthen its position as a regional and global reference regulator.

“In 2022, HSA was the first international regulator to achieve the World Health Organization (WHO) Maturity Level 4 status and was amongst the first three regulators recognised as a WHO Listed Authority,” Ong said.

Second, the government will coordinate across agencies to support biomedical companies establishing operations in the country.

These include the Agency for Science, Technology and Research to support translational research and innovation, the Singapore Economic Development Board to facilitate manufacturing investment, and HSA to provide regulatory oversight and product registration.

“We will explore opportunities to align companies’ product offerings with Singapore's priority disease areas, such as cardiovascular diseases, diabetes, and metabolic disorders,” the health minister added.

The HSA will also update regulatory frameworks as technologies evolve, as advances in artificial intelligence (AI), genomics, and precision medicine also introduce potential risks and ethical considerations.

As part of this effort, the government has launched AI in Healthcare Guidelines (AIHGle) 2.0, updating the original framework introduced in 2021.

Ong said the revised guidelines address developments in artificial intelligence, including generative AI.

Regulatory sandboxes will also be set up to evaluate AI solutions in real-world healthcare settings, he added.

If you've been wondering whether SBR could work for your company — yes, probably.

A lot of the companies we partner with started as readers. They'd been following our coverage for a while, saw their own customers and competitors in it, and eventually asked the obvious question: could we do something with you? The answer is usually yes. The shape of it depends on what you're trying to do.

The options are broader than most people assume — thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. Some partners use one channel; most use a mix. We figure out the right combination by starting with your brief, not with our rate card.

So if the question has been on your mind, here's the easy way to ask it.

We'll tell you honestly whether we can help, and how. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia